Abstract:
A method of controlling emesis caused by anticancer drugs with 2-alkoxy-N-(1-azabicyclo[2. 2. 2]oct-3-yl) benzamide-N-oxides having the formula: ##STR1## wherein R. sub. 1 is loweralkyl, and R. sub. 2 is selected from the group consisting of hydrogen, halo, 4,5-benzo, methylsulfonyl, loweralkoxy or Am and n is 1 or 2, and the pharmaceutically acceptable acid addition salts thereof is disclosed.